Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04272086 · ClinicalTrials.gov registry record · Phase 4
Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy
A Phase 4 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
NCT04272086 is a Phase 4 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 140 participants.
The verdict
NCT04272086, a Phase 4 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
Study Summary
The study team will be randomizing patients presenting for open myomectomy to either received transversus abdominal plane blocks with either liposomal bupivacaine or standard bupivacaine. The study team will be analyzing the impact of local anesthetic on opiate consumption as the investigator's primary endpoint with other secondary endpoints.
Interventions
- DRUG Bupivacaine
- DRUG normal saline
- DRUG Bupivacaine liposome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2025-10-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04272086
The ClinicalTrials.gov registry entry for NCT04272086 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.
NCT04272086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04272086 about?
NCT04272086 is a clinical study titled "Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy". The study team will be randomizing patients presenting for open myomectomy to either received transversus abdominal plane blocks with either liposomal bupivacaine or standard bupivacaine. The study team will be analyzing the impact of local anesthetic on opiate consumption as the investigator's prim...
What is the current status of trial NCT04272086?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2020-11-09. Estimated completion is 2025-10-28.
What interventions are being tested in trial NCT04272086?
The interventions under investigation include: Bupivacaine (DRUG), normal saline (DRUG), Bupivacaine liposome (DRUG).
Who is sponsoring clinical trial NCT04272086?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.